Total Payments
$4,243
2024 Payments
$578.17
Companies
11
Transactions
80
Medicare Patients
762
Medicare Billing
$80,032
Payment Breakdown by Category
Food & Beverage$4,081 (96.2%)
Education$161.99 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,081 | 78 | 96.2% |
| Education | $161.99 | 2 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,464 | 32 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,065 | 14 | $0 (2023) |
| Incyte Corporation | $478.26 | 5 | $0 (2024) |
| GENZYME CORPORATION | $373.95 | 7 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $308.93 | 10 | $0 (2022) |
| Janssen Biotech, Inc. | $142.67 | 3 | $0 (2024) |
| PFIZER INC. | $117.32 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $110.94 | 1 | $0 (2023) |
| UCB, Inc. | $96.48 | 1 | $0 (2024) |
| Lilly USA, LLC | $60.45 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $578.17 | 5 | ABBVIE INC. ($261.98) |
| 2023 | $753.36 | 6 | Incyte Corporation ($248.29) |
| 2022 | $1,729 | 48 | ABBVIE INC. ($577.24) |
| 2021 | $817.84 | 17 | AbbVie Inc. ($369.86) |
| 2020 | $118.20 | 2 | AbbVie Inc. ($118.20) |
| 2019 | $123.97 | 1 | GENZYME CORPORATION ($123.97) |
| 2018 | $122.52 | 1 | Regeneron Healthcare Solutions, Inc. ($122.52) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $137.95 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $111.34 | General |
| Category: Dermatology | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $108.37 | General |
| Category: Immunology | ||||||
| 03/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $96.48 | General |
| Category: Immunology | ||||||
| 11/29/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $136.57 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $132.56 | General |
| Category: Immunology | ||||||
| 02/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/22/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $123.60 | General |
| Category: Dermatology | ||||||
| 02/01/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $110.94 | General |
| Category: Immunology | ||||||
| 01/25/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $124.69 | General |
| Category: Dermatology | ||||||
| 12/08/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/30/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $99.99 | General |
| Category: Inflammation & Immunology | ||||||
| 06/17/2022 | Sun Pharmaceutical Industries Inc. | — | Education | In-kind items and services | $81.99 | General |
| 06/17/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Dermatology | ||||||
| 06/17/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: Dermatology | ||||||
| 06/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $118.79 | General |
| Category: IMMUNOLOGY | ||||||
| 06/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2022 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 05/13/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $100.19 | General |
| Category: Dermatology | ||||||
| 05/04/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $116.15 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 564 | 861 | $222,653 | $60,155 |
| 2022 | 7 | 198 | 272 | $69,590 | $19,877 |
Total Patients
762
Total Services
1,133
Medicare Billing
$80,032
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 167 | $41,249 | $12,809 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $48,198 | $12,180 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 89 | $32,396 | $9,979 | 30.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 103 | 103 | $37,595 | $9,973 | 26.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 63 | 66 | $24,552 | $6,720 | 27.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 62 | 77 | $18,942 | $4,299 | 22.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 22 | 23 | $11,753 | $2,490 | 21.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 47 | 249 | $7,968 | $1,705 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $17,216 | $4,702 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $16,638 | $4,586 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 53 | $12,720 | $4,402 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 22 | $7,766 | $2,504 | 32.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 21 | 21 | $7,413 | $1,968 | 26.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 22 | 23 | $5,543 | $1,201 | 21.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 15 | 74 | $2,294 | $513.47 | 22.4% |
About Dr. Dev Chahal, MD
Dr. Dev Chahal, MD is a Dermatology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1770018236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dev Chahal, MD has received a total of $4,243 in payments from pharmaceutical and medical device companies, with $578.17 received in 2024. These payments were reported across 80 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($4,081).
As a Medicare-enrolled provider, Chahal has provided services to 762 Medicare beneficiaries, totaling 1,133 services with total Medicare billing of $80,032. Data is available for 2 years (2022–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Oakland, CA
- Active Since 04/21/2017
- Last Updated 08/03/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1770018236
Products in Payments
- SKYRIZI (Biological) $1,034
- DUPIXENT (Biological) $1,020
- OPZELURA (Drug) $478.26
- RINVOQ (Biological) $290.10
- ILUMYA (Biological) $188.92
- HUMIRA (Biological) $139.76
- DUPIXENT (Drug) $123.97
- DUPIXENT DUPILUMAB INJECTION (Biological) $122.52
- Sotyktu (Drug) $110.94
- TREMFYA (Drug) $108.37
- CIBINQO (Drug) $99.99
- Bimzelx (Biological) $96.48
- TALTZ (Drug) $60.45
- Ilumya (Biological) $38.02
- REMICADE (Biological) $34.30
- COSENTYX (Biological) $24.89
- LIBTAYO (Biological) $23.13
- EUCRISA (Drug) $17.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Oakland
Ingrid Roseborough, M.d, M.D
Dermatology — Payments: $16,677
Dermatology $16,677
Julia Muller, M.d, M.D
Dermatology — Payments: $12,024
Dermatology $12,024
Jason Fung, Md, MD
Dermatology — Payments: $8,119
Dermatology $8,119
Ani Tajirian, M.d, M.D
Dermatology — Payments: $7,841
Dermatology $7,841
Harvind Chahal, Md, MD
Dermatology — Payments: $7,685
Dermatology $7,685
William Littman, Md, MD
Dermatology — Payments: $5,324
Dermatology $5,324